Transgene SA (TNG) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Virbac SA

Valneva SE

EUROAPI SA

Transgene SA

Inventiva SA

Acticor Biotech SAS

Pharnext SA

Aelis Farma SA

Afyren SAS

Valbiotis SA

genOway SA

Why is Transgene SA ?

Flat results in Jun 25

INTEREST(HY) At EUR 0.92 MM has Grown at 69.74%
PRE-TAX PROFIT(Q) Lowest at EUR -23.71 MM
NET PROFIT(Q) Lowest at EUR -19.35 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 11.77%, its profits have fallen by -52%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Transgene SA for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Transgene SA

-100.0%

-0.79

77.00%

France CAC 40

0.34%

-0.10

17.53%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-64.00%

EBIT Growth (5y)

-7.36%

EBIT to Interest (avg)

-30.14

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.42

Sales to Capital Employed (avg)

0.06

Tax Ratio

15.11%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-59.34

EV to EBIT

-5.42

EV to EBITDA

-5.60

EV to Capital Employed

22.34

EV to Sales

227.66

PEG Ratio

Dividend Yield

ROCE (Latest)

-412.17%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at EUR -19.35 MM

ROCE(HY)

Highest at 0%

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -382.77 %

-5What is not working for the Company

INTEREST(HY)

At EUR 0.92 MM has Grown at 69.74%

PRE-TAX PROFIT(Q)

Lowest at EUR -23.71 MM

NET PROFIT(Q)

Lowest at EUR -19.35 MM

Here's what is working for Transgene SA

Debt-Equity Ratio

Lowest at -382.77 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Transgene SA

Interest

At EUR 0.92 MM has Grown at 69.74%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (EUR MM)

Pre-Tax Profit

Lowest at EUR -23.71 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (EUR MM)

Net Profit

Lowest at EUR -19.35 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (EUR MM)